NCT00301119View on ClinicalTrials.gov

Lung Cancer Biomarkers and Screening

RecruitingOBSERVATIONAL
Enrollment

10,850

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

May 31, 2030

Study Completion Date

May 31, 2030

Conditions
Lung Cancer
Trial Locations (1)

10016

RECRUITING

NYU Cancer Institute at New York University Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT00301119 - Lung Cancer Biomarkers and Screening | Biotech Hunter | Biotech Hunter